Results 71 to 80 of about 12,445,360 (313)

Energy efficient privacy preserved data gathering in wireless sensor networks having multiple sinks [PDF]

open access: yes, 2009
Wireless sensor networks (WSNs) generally have a many-to-one structure so that event information flows from sensors to a unique sink. In recent WSN applications, many-tomany structures are evolved due to need for conveying collected event information to ...
Bahsi, Hayretdin   +2 more
core   +1 more source

Time Distortion Anonymization for the Publication of Mobility Data with High Utility [PDF]

open access: yes, 2015
An increasing amount of mobility data is being collected every day by different means, such as mobile applications or crowd-sensing campaigns. This data is sometimes published after the application of simple anonymization techniques (e.g., putting an ...
Brunie, Lionel   +3 more
core   +3 more sources

Mastering data privacy: leveraging K-anonymity for robust health data sharing

open access: yesInternational Journal of Information Security
In modern healthcare systems, data sources are highly integrated, and the privacy challenges are becoming a paramount concern. Despite the critical importance of privacy preservation in safeguarding sensitive and private information across various ...
Stylianos Karagiannis   +4 more
semanticscholar   +1 more source

A K-Anonymity Based Schema for Location Privacy Preservation

open access: yesIEEE Transactions on Sustainable Computing, 2019
In recent years, with the development of mobile devices, the location based services (LBSs) have become more and more prevailing and most applications installed on these devices call for location information.
Fan Fei   +5 more
semanticscholar   +1 more source

Implementing Health‐Related Quality of Life Assessment in Pediatric Oncology: A Feasibility Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background There is growing interest in embedding health‐related quality of life (HRQoL) assessment and patient‐reported outcome measures (PROMs) within clinical cancer care. This study evaluated the feasibility, acceptability, and usability of implementing an electronic PROM (ePROM) platform to measure HRQoL in children with cancer ...
Mikaela Doig   +13 more
wiley   +1 more source

Distinguishable de-identified faces [PDF]

open access: yes, 2015
The k-anonymity approach adopted by k-Same face de-identification methods enables these methods to serve their purpose of privacy protection. However, it also forces every k original faces to share the same de-identified face, making it impossible to ...
Ariyaeeinia, A., Meng, Li, Sun, Zongji
core   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

The k-Anonymity Problem Is Hard [PDF]

open access: yes, 2009
21 pages, A short version of this paper has been accepted in FCT 2009 - 17th International Symposium on Fundamentals of Computation ...
Bonizzoni, P, Della Vedova, G, Dondi, R
openaire   +3 more sources

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy